BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 18028019)

  • 1. Potential of urinary biomarkers in early bladder cancer diagnosis.
    Lam T; Nabi G
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1105-15. PubMed ID: 18028019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bladder cancer biomarkers].
    Dobrowolska-Glazar B; Glazar W; Dobrowolski Z; Lipczyński W
    Przegl Lek; 2010; 67(7):479-83. PubMed ID: 21387760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?
    Yutkin V; Nisman B; Pode D
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):787-90. PubMed ID: 20553203
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
    Yossepowitch O; Herr HW; Donat SM
    J Urol; 2007 Apr; 177(4):1277-82; discussion 1282. PubMed ID: 17382711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic assays for the detection of urothelial cancer.
    Gaston KE; Grossman HB
    Methods Mol Biol; 2010; 641():303-23. PubMed ID: 20407954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer.
    Lintula S; Hotakainen K
    Expert Opin Biol Ther; 2010 Aug; 10(8):1169-80. PubMed ID: 20446896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of tumor markers in bladder cancer surveillance.
    Hong YM; Loughlin KR
    Urology; 2008 Jan; 71(1):131-5. PubMed ID: 18242381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in bladder cancer diagnostics.
    Sanchez-Carbayo M
    Clin Biochem; 2004 Jul; 37(7):562-71. PubMed ID: 15234237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NMP-22 test. Is it useful in the follow-up of patients with superficial bladder tumor?].
    Pérez García FJ; Eyo A; Escaf Barmadah S; Fernández Gómez JM
    Arch Esp Urol; 2002 Dec; 55(10):1201-8. PubMed ID: 12611217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic test for bladder cancer: the NMP22®].
    Saint F; Quintens H; Roupret M; Amsellem-Ouazana D; Mazerolles C; Wallerand H; Bernardini S; Guy L; Soulié M; Pfister C;
    Prog Urol; 2011 Apr; 21(4):245-9. PubMed ID: 21482397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary bladder tumor markers.
    Lokeshwar VB; Selzer MG
    Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.
    Mao Y; Zhao X; Wang S; Cheng Y
    Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary biomarkers of bladder cancer: an update and future perspectives.
    Rosser CJ; Urquidi V; Goodison S
    Biomark Med; 2013 Oct; 7(5):779-90. PubMed ID: 24044570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.
    Mian C; Lodde M; Comploj E; Palermo S; Mian M; Maier K; Pycha A
    Anticancer Res; 2005; 25(5):3641-4. PubMed ID: 16101194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?
    de Bekker-Grob EW; van der Aa MN; Zwarthoff EC; Eijkemans MJ; van Rhijn BW; van der Kwast TH; Steyerberg EW
    BJU Int; 2009 Jul; 104(1):41-7. PubMed ID: 19500328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary markers in the detection of bladder cancer: what's new?
    Nielsen ME; Schaeffer EM; Veltri RW; Schoenberg MP; Getzenberg RH
    Curr Opin Urol; 2006 Sep; 16(5):350-5. PubMed ID: 16905981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary markers in bladder cancer.
    Vrooman OP; Witjes JA
    Eur Urol; 2008 May; 53(5):909-16. PubMed ID: 18162285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?
    Sapre N; Anderson PD; Costello AJ; Hovens CM; Corcoran NM
    Urol Oncol; 2014 Jan; 32(1):48.e9-17. PubMed ID: 24140246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.